Impact of Remimazolam on Prognosis After Bladder Cancer Surgery

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(6 sites)

China

Beijing Tsinghua Chang Gung Hospital, Beijing, Beijing Municipality

The Sixth Medical Center of PLA General Hospital, Beijing, Beijing Municipality

Peking University First Hospital, Beijin, Bejing

Guizhou Provincial People's Hospital, Guiyang, Guizhou

Jiangsu Provincial People's Hospital, Nanjing, Jiangsu

Shanghai 10th People's Hospital, Shanghai, Shanghai Municipality